Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Prepaid Assets: 2023-2025

Historic Prepaid Assets for Contineum Therapeutics (CTNM) over the last 2 years, with Sep 2025 value amounting to $2.5 million.

  • Contineum Therapeutics' Prepaid Assets rose 104.55% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 104.55%. This contributed to the annual value of $1.6 million for FY2024, which is 35.29% down from last year.
  • As of Q3 2025, Contineum Therapeutics' Prepaid Assets stood at $2.5 million, which was up 85.98% from $1.4 million recorded in Q2 2025.
  • Contineum Therapeutics' 5-year Prepaid Assets high stood at $2.5 million for Q3 2025, and its period low was $1.2 million during Q3 2024.
  • For the 3-year period, Contineum Therapeutics' Prepaid Assets averaged around $1.8 million, with its median value being $1.6 million (2024).
  • As far as peak fluctuations go, Contineum Therapeutics' Prepaid Assets tumbled by 35.29% in 2024, and later skyrocketed by 104.55% in 2025.
  • Contineum Therapeutics' Prepaid Assets (Quarterly) stood at $2.5 million in 2023, then crashed by 35.29% to $1.6 million in 2024, then soared by 104.55% to $2.5 million in 2025.
  • Its Prepaid Assets was $2.5 million in Q3 2025, compared to $1.4 million in Q2 2025 and $1.4 million in Q1 2025.